Growth and safety of infants with cow’s milk allergy receiving a new hydrolyzed rice protein-based formula containing 2-fucosyllactose and lacto-N-neotetraose: protocol for a randomized clinical trial. The RIGHT-GO study (opens in new tab)
Hydrolyzed rice formulas (HRF) are recommended by expert societies as a suitable option for the management of non-breastfed infants with cow’s milk allergy (CMA). There is a growing trend towards the use of HRF driven by their plant-based source, appealing taste, and established safety and efficacy. Human milk oligosaccharides (HMOs) play a significant role in promoting gut and immune health of infants. There is currently no evidence regarding the growth and safety of infants receiving HRF co...
Read the original article